会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • METHODS AND APPARATUS FOR MAKING PARTICLES USING SPRAY DRYER AND IN-LINE JET MILL
    • 使用喷雾干燥机和在线喷射机制造颗粒的方法和装置
    • WO2004060547A1
    • 2004-07-22
    • PCT/US2003/037108
    • 2003-11-20
    • ACUSPHERE, INC.
    • CHICKERING, Donald, E., IIINARASIMHAN, SridharALTREUTER, DavidKOPESKY, PaulKEEGAN, MarkSTRAUB, Julie, A.BERNSTEIN, Howard
    • B01J2/04
    • F26B17/102A61K9/1647A61K9/1688B01D1/18B01J2/04F26B3/12
    • Methods and apparatus are provided for making particles comprising: (a) spraying an emulsion, solution, or suspension, which comprises a solvent and a bulk material (e.g., a pharmaceutical agent), through an atomizer (14) and into a primary drying chamber (12), having a drying gas flowing therethrough, to form droplets comprising the solvent and bulk material dispersed in the drying gas; (b) evaporating, in the primary drying chamber (12), at least a portion of the solvent into the drying gas to solidify the droplets and form particles dispersed in drying gas; and (c) flowing the particles and at least a portion of the drying gas through a jet mill (24) to deagglomerate or grind the particles. By coupling spray drying with "in-line" jet milling, a single step process is created from two separate unit operations, and an additional collection step is advantageously eliminated. The one-step, in-line process has further advantages in time and cost of processing.
    • 提供了用于制备颗粒的方法和装置,包括:(a)通过雾化器(14)将包含溶剂和散装材料(例如药剂)的乳液,溶液或悬浮液喷雾到初级干燥室 (12),其具有流过其中的干燥气体,以形成包含分散在干燥气体中的溶剂和散装材料的液滴; (b)在主干燥室(12)中将至少一部分溶剂蒸发到干燥气体中以固化液滴并形成分散在干燥气体中的颗粒; 和(c)使颗粒和至少一部分干燥气体流过喷射磨机(24)以使颗粒解聚或研磨。 通过将喷雾干燥与“直列式”喷射式研磨相结合,由两个单独的单元操作产生单步骤,有利地消除了另外的收集步骤。 一步一步的在线过程在处理时间和成本方面具有进一步的优势。
    • 7. 发明申请
    • SUSTAINED RELEASE POROUS MICROPARTICLES FOR INHALATION
    • 持续释放多孔微波炉用于吸入
    • WO2004030659A1
    • 2004-04-15
    • PCT/US2003/030835
    • 2003-09-30
    • ACUSPHERE, INC.
    • BERNSTEIN, HowardCHICKERING, III, Donald, E.HUANG, Eric, K.NARASIMHAN, SridharREESE, ShainaSTRAUB, Julie, A.
    • A61K9/72
    • A61K9/0075A61K9/008A61K9/1611A61K9/1617A61K9/1647A61K31/00A61K31/56A61K31/58
    • Pharmaceutical formulations and methods are provided for the sustained delivery of a pharmaceutical agent to the lungs of a patient by inhalation. The formulation includes porous microparticles which comprise a pharmaceutical agent and a matrix material, wherein upon inhalation of the formulation a therapeutically or prophylactically effective amount of the pharmaceutical agent is released from the microparticles in the lungs for at least 2 hours. Preferably, a majority of the pharmaceutical agent is released from the microparticles by 24 hours following inhalation, for example where a majority of the pharmaceutical agent is released no earlier than about 2 hours and no later than about 24 hours following inhalation. Methods for delivering a pharmaceutical agent, such as a corticosteroid, to the lungs of a patient are also provided. For example, the method includes having the patient inhale a dry powder blend comprising the present microparticles and a pharmaceutically acceptable bulking agent.
    • 提供药物制剂和方法用于通过吸入将药剂持续递送至患者的肺。 制剂包括包含药剂和基质材料的多孔微粒,其中在吸入制剂时,治疗或预防有效量的药剂从肺中的微粒释放至少2小时。 优选地,大多数药剂在吸入之后24小时从微粒释放,例如大多数药剂在吸入后不早于约2小时且不迟于约24小时释放。 还提供了将药剂如皮质类固醇递送到患者的肺的方法。 例如,该方法包括使患者吸入包含本发明的微粒和药学上可接受的填充剂的干粉混合物。